Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial OfficerAccesswire • Thursday
Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024Accesswire • 11/27/24
Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) PlatformAccesswire • 11/14/24
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support GrowthAccesswire • 11/07/24
Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology PlatformAccesswire • 10/24/24
Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ETAccesswire • 10/23/24
Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal ConferenceAccesswire • 10/15/24
Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in EuropeAccesswire • 10/03/24
Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, MinnesotaAccesswire • 09/11/24
Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market OpportunitiesAccesswire • 09/05/24
Zomedica's Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred ProductAccesswire • 08/29/24
Zomedica Introduces Enhanced Audio Features for the VETGuardian(R) Zero-touch Vital Signs Remote Monitoring SystemAccesswire • 08/22/24
More Than $9M Bet On Nerdy? Check Out These 3 Penny Stocks Executives Are Aggressively BuyingBenzinga • 08/21/24
Zomedica Announces Key Educational Presentations at Fetch dvm360 Veterinary ConferenceAccesswire • 08/20/24
Zomedica Announces Second Quarter 2024 Financial Results: Revenue of $6.1 Million; 71% Gross Margin, and $83.0 Million in Liquidity to Support GrowthAccesswire • 08/14/24
Zomedica Continues Global Expansion Through Strategic Partnership with SIRE Veterinario, S.A for Sales Expansion in Central AmericaAccesswire • 08/14/24
Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ETAccesswire • 08/01/24
The United States Eventing Association Names Zomedica's PulseVet(R) as the Official Shock Wave of the USEAAccesswire • 07/17/24
Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International MarketsAccesswire • 07/09/24
US Equestrian Names Zomedica's PulseVet System as the Official Shock Wave Therapy of US Equestrian Team VeterinariansAccesswire • 07/01/24
Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the PlatformAccesswire • 06/27/24